首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Revisiting The Mechanism Of Macrolide-antibiotic Resistance Mediated By Ribosomal Protein L22
【24h】

Revisiting The Mechanism Of Macrolide-antibiotic Resistance Mediated By Ribosomal Protein L22

机译:核糖体蛋白L22介导的大环内酯类抗生素耐药机制的再探讨

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Bacterial antibiotic resistance can occur by many mechanisms. An intriguing class of mutants is resistant to macrolide antibiotics even though these drugs still bind to their targets. For example, a 3-residue deletion (ΔMKR) in ribosomal protein L22 distorts a loop that forms a constriction in the ribosome exit tunnel, apparently allowing nascent-chain egress and translation in the presence of bound macrolides. Here, however, we demonstrate that AMKR and wild-type ribosomes show comparable macrolide sensitivity in vitro. In Escherichia coli, we find that this mutation reduces antibiotic occupancy of the target site on ribosomes in a manner largely dependent on the AcrAB-TolC efflux system. We propose a model for antibiotic resistance in which AMKR ribosomes alter the translation of specific proteins, possibly via changes in programmed stalling, and modify the cell envelope in a manner that lowers steady-state macrolide levels.
机译:细菌抗生素抗性可以通过许多机制发生。有趣的一类突变体对大环内酯类抗生素具有抗性,即使这些药物仍与它们的靶标结合。例如,核糖体蛋白L22中的3个残基缺失(ΔMKR)扭曲了一个环,该环在核糖体出口通道中形成缩颈,显然在结合大环内酯存在的情况下允许新生链外出和翻译。然而,在这里,我们证明AMKR和野生型核糖体在体外显示出可比的大环内酯敏感性。在大肠杆菌中,我们发现此突变以很大程度上依赖于AcrAB-TolC外排系统的方式降低了核糖体上靶位点的抗生素占用。我们提出了一种抗生素抗性模型,其中AMKR核糖体可能通过编程的失速变化来改变特定蛋白质的翻译,并以降低稳态大环内酯水平的方式修饰细胞膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号